Table 2.
Variable | Intervention Comparison, GMR (95% CI) |
||
---|---|---|---|
N-9 vs Normosol-R | N-9 vs CS + BX | CS + BX vs Normosol-R | |
Plasma 99mTc AUC | 8.3 (4.7–15.6)a | 5.7 (3.4–9.4)a | 1.5 (.7–3.3) |
Plasma 99mTc Cmax | 12.0 (6.8–21.0)a | 8.4 (5.2–13.5)a | 1.4 (.7–3.1) |
Plasma 99mTc Tmax | 0.21 (.15–.28)a | 0.40 (.25–.66)a | 0.52 (.29–.94)a |
Urine 99mTc level, h after intervention receipt | |||
0–2 | 12.2 (6.3–23.6)a | 5.0 (3.1–8.2)a | 2.4 (1.0– 5.8)a |
2–4 | 5.0 (2.1–11.8)a | 4.0 (1.4–11.4)a | 1.3 (.5–3.8) |
4–8 | 3.6 (1.1–11.4)a | 1.6 (.7–3.4) | 2.3 (.5–9.6) |
8–12 | 2.8 (.7–10.6) | 1.7 (.7–4.1) | 1.7 (.4–7.8) |
12–24 | 1.9 (.8–4.7) | 1.7 (.6–4.8) | 1.2 (.4–4.3) |
Abbreviations: AUC, area under the curve; CI, confidence interval; Cmax, maximum concentration; CS + BX, Normosol-R plus coital simulation and endoscopic biopsy; N-9, nonoxynol-9; Tmax, time to maximum concentration; 99mTc, 99mtechnetium.
a P < .05, using the t test for pairwise comparison.